Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Need-based cancer survivorship program implementation

Official title: Evaluating the Implementation of a Need-based Cancer Survivorship Program Using the REAIM Framework

Run by The University of Hong Kong · NCT07830368 · Data updated 2026-11-12

This project tests a need-based survivorship program for adults who have finished cancer treatment to see if targeted screenings and referrals can help manage symptoms and weight concerns.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment12500 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations5 sites (Hong Kong, Hong Kong and 4 other locations)
StatusRecruiting
StartedMarch 2, 2026
Main results expectedFebruary 27, 2031
Study endsFebruary 27, 2032
Registry record updatedSeptember 21, 2026
Trial IDNCT07830368 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese- or English-speaking adults 18+ within three years post-treatment, attending specialized outpatient surveillance clinics in Hong Kong.

Probably not a fit

Patients who are outside the three-year post-treatment window or non-Chinese/English speakers may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an implementation study that applies the RE-AIM framework to deploy a need-based survivorship program in collaboration with NGOs and district health centers. It uses structured screening with the Edmonton Symptom Assessment System (ESAS) and a new framework for weight-related needs to identify moderate-to-high needs and refer survivors to appropriate services. The study plans to screen about 12,500 cancer survivors and collects quantitative and qualitative data to understand reach, effectiveness, adoption, implementation, and maintenance. Participants include Chinese- or English-speaking adults within three years post-treatment attending surveillance clinics; peer volunteers with lived cancer experience may also participate. The lead sponsor is The University of Hong Kong, with sites at several Queen Mary Hospital departments and PYEH in Hong Kong.

Why it matters

Potential benefit: If successful, the program could provide timely symptom support and weight-related guidance to a large group of survivors, improving quality of life.

How similar studies have gone: Previous implementations of survivorship care models show promise in improving symptom management, though this exact need-based, large-scale approach is innovative in its explicit screening and referral framework.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: (Cancer patients)

* Chinese/English speaking adult cancer patients aged 18 years or older
* Within three years post-treatment attending the specialized outpatient clinics for surveillance

Exclusion Criteria: (Cancer patients)

* Non-Chinese or non-English speaking
* Childhood cancer survivors
* More than three years post-treatment
* and/or unable to provide informed consent

Inclusion Criteria: (Peer volunteers)

* Aged 18 years or older
* Able to communicate in Chinese or English
* Have lived experience as a cancer survivor or caregiver

Where it's running

  • Queen Mary Hospital-Department of Surgery
    Hong Kong, Hong Kong, Hong Kong
    Recruiting
  • PYEH Department of Clinical Oncology
    Hong Kong, Hong Kong
    Recruiting
  • Queen Mary Hospital-Department of Obstetrics & Gynaecology
    Hong Kong, Hong Kong
    Recruiting
  • Queen Mary Hospital-Department of Oncology
    Hong Kong, Hong Kong
    Recruiting
  • Queen Mary Hospital
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.